These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10070087)

  • 1. Maintenance of blood pressure in normotensive dogs by endothelin.
    Münter K; Ehmke H; Kirchengast M
    Am J Physiol; 1999 Mar; 276(3):H1022-7. PubMed ID: 10070087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow.
    Berthold H; Just A; Kirchheim HR; Ehmke H
    Hypertension; 1999 Dec; 34(6):1254-8. PubMed ID: 10601127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the renin-angiotensin system by endothelin subtype A receptor blockade in conscious dogs.
    Berthold H; Münter K; Just A; Kirchheim HR; Ehmke H
    Hypertension; 1999 Jun; 33(6):1420-4. PubMed ID: 10373226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of endothelin to renal vascular tone and autoregulation in the conscious dog.
    Berthold H; Münter K; Just A; Kirchheim HR; Ehmke H
    Am J Physiol; 1999 Mar; 276(3):F417-24. PubMed ID: 10070165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
    Richard V; Hogie M; Thuillez C
    Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trandolapril and endothelin antagonist LU-135252 in the treatment of the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat.
    Ezra-Nimni O; Ezra D; Peleg E; Munter K; Rosenthal T
    Am J Hypertens; 2003 Apr; 16(4):324-8. PubMed ID: 12670751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats.
    Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic, renal, and endocrine responses to acute ET(A) blockade at different ANG II plasma levels.
    Boemke W; Hocher B; Schleyer N; Krebs MO; Kaczmarczyk G
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1322-31. PubMed ID: 11294750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A; Amann K; Wagner J; Gehlen F; Münter K; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of AT(1) and ET(A) receptor blockade in a transgenic, angiotensin II-dependent, rat model.
    Bohlender J; Gerbaulet S; Krämer J; Gross M; Kirchengast M; Dietz R
    Hypertension; 2000 Apr; 35(4):992-7. PubMed ID: 10775574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II and endothelin-1 receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs.
    Francis RC; Höhne C; Kaczmarczyk G; Boemke W
    Acta Physiol Scand; 2004 Apr; 180(4):319-28. PubMed ID: 15030373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous nitric oxide reduces the efficacy of the endothelin system to maintain blood pressure during high epidural anaesthesia in conscious dogs.
    Beck C; Schwarte LA; Schindler AW; Scheeren TW; Picker O
    Eur J Anaesthesiol; 2007 Aug; 24(8):689-96. PubMed ID: 17437657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
    J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
    Hofman C; Gabai E; Peleg E; Munter K; Rosenthal T
    Blood Press; 2005; 14(2):114-9. PubMed ID: 16036489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalaprilat, losartan and LU 135252 in coronary blood flow regulation.
    Rigol M; Heras M; Solanes N; Epelde F; Roig E; Pérez-Villa F; Roqué M; Sanz G
    Eur J Clin Invest; 2003 May; 33(5):363-9. PubMed ID: 12713448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    Matrougui K; Lévy BI; Henrion D
    Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
    Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
    Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.